Effectiveness and Safety of Adding Basal Insulin Glargine in Patients with Type 2 Diabetes Mellitus Exhibiting Inadequate Response to Metformin and DPP-4 Inhibitors with or without Sulfonylurea
Yu Mi Kang (Kang YM), Chang Hee Jung (Jung CH), Seung-Hwan Lee (Lee SH), Sang-Wook Kim (Kim SW), Kee-Ho Song (Song KH), Sin Gon Kim (Kim SG), Jae Hyeon Kim (Kim JH), Young Min Cho (Cho YM), Tae Sun Park (Park TS), Bon Jeong Ku (Ku BJ), Gwanpyo Koh (Koh G), Dol Mi Kim (Kim DM), Byung-Wan Lee (Lee BW), Joong-Yeol Park (Park JY)
Diabetes Metab J. 2019;43(4):432-446.   Published online 2019 Jun 19     DOI: https://doi.org/10.4093/dmj.2018.0092
Citations to this article as recorded by Crossref logo
Glycaemic control with add‐on thiazolidinedione or a sodium‐glucose co‐transporter‐2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24‐week, randomized controlled trial
Jaehyun Bae, Ji Hye Huh, Minyoung Lee, Yong‐Ho Lee, Byung‐Wan Lee
Diabetes, Obesity and Metabolism.2021; 23(2): 609.     CrossRef
Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
Kyung-Soo Kim, Byung-Wan Lee
Clinical and Molecular Hepatology.2020; 26(4): 430.     CrossRef